Dmitry Y Guschin

This inventor holds 21 USPTO granted patents and 1 published patent application, plus 5 CIPO patents and 10 EPO patents. Top assignees: Sangamo Therapeutics, Inc., Dow Agrosciences LLC, Sangamo Biosciences, Inc.. Active years: 2003-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dmitry Y Guschin. Retrieved from https://idiyas.com/inventor/dmitry-y-guschin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 1)

% Patents Active = 85.7

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 7)

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 122(Granted Patents)

Location History:

Gyeonggi-do, KR (2019 - 2021)
Richmond, CA (US) (2003 - 2022)

Company Filing History:

15 out of 153

Sangamo Therapeutics, Inc.

Sangamo Biosciences, Inc.

patents

4. 1 out of 116

Corteva Agriscience LLC

patents

where one patent can have more than one assignee

Years Active: 2003-2022

Loading Chart...

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11492643 - Methods and compositions for treatment of a genetic condition (2022-11-08),

2. 11198883 - Methods and compositions for integration of an exogenous sequence within the genome of plants (2021-12-14),

3. 11085092 - Targeted modification of malate dehydrogenase (2021-08-10),

4. 10961540 - FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks (2021-03-30),

5. 10844389 - FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks (2020-11-24),

6. 10669557 - Targeted deletion of cellular DNA sequences (2020-06-02),

7. 10577616 - FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks (2020-03-03),

8. 10526610 - FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks (2020-01-07),

9. 10501748 - Methods and compositions for integration of an exogenous sequence within the genome of plants (2019-12-10),

10. 10358684 - Targeted modification of malate dehydrogenase (2019-07-23),

11. 10287595 - Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks (2019-05-14),

12. 9963715 - Methods and compositions for treatment of a genetic condition (2018-05-08),

13. 9963711 - FAD2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks (2018-05-08),

14. 9914930 - FAD3 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks (2018-03-13),

15. 9695442 - Targeted deletion of cellular DNA sequences (2017-07-04),

Title: The Innovative Journey of Dmitry Y Guschin

Introduction: Dmitry Y Guschin is a pioneering inventor based in Richmond, California, whose work has significantly impacted various industries through his groundbreaking innovations.

Latest Patents: Dmitry Y Guschin holds several patents in the fields of technology and engineering, with his most recent inventions focusing on renewable energy solutions and sustainable transportation methods.

Career Highlights: Throughout his illustrious career, Dmitry Y Guschin has been recognized for his exceptional contributions to the field of innovation, receiving numerous awards for his inventive spirit and dedication to creating a more sustainable future.

Collaborations: Dmitry Y Guschin has collaborated with leading research institutions, universities, and companies to further develop and implement his innovative ideas, showcasing his ability to work across disciplines to bring his inventions to life.

Conclusion: Dmitry Y Guschin's passion for innovation and commitment to creating a positive impact on the world make him a truly remarkable inventor whose work will continue to inspire future generations of innovators.

Profile summary based on public USPTO records.